Extract
Bentley Board Approves Spin-off of Drug Delivery Business.
Bentley Sets July 22, 2008 as Date for Stockholders to Vote on Proposed Acquisition by Teva Pharmaceutical Industries Ltd.
EXETER, N.H. -- The board of directors of Bentley Pharmaceuticals, Inc. (NYSE: BNT) today approved the spin-off of its drug delivery business into a new publicly traded company to be called CPEX Pharmaceuticals, Inc. CPEX is a drug delivery company involved in the business of de...See the full content of this document
Sponsored links
